Application of Artificial Intelligence to Analyze Data from Randomized Controlled Trials: An Example from DECAAF-II

DECAAF: Delayed Enhancement Catheter Ablation of Atrial Fibrillation

[www.heartrhythmjournal.com]

From 2013:
[www.escardio.org]

From 2021:
[www.acc.org]

BTW, ALL studies above (2013, 2021, 2025) had the same principal investigator— Nassir Marrouche, MD. I plan on following his progress in the future. He is on to something.

You can reach him here: [medicine.tulane.edu]

We are advancing since 2013. Perhaps AI mapping may be the norm one day.



Edited 3 time(s). Last edit at 01/14/2025 09:17AM by susan.d.